APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $26,005,000 | +23.6% | 411,471 | -16.1% | 3.07% | +53.4% |
| Q1 2021 | $21,046,000 | -25.0% | 490,471 | 0.0% | 2.00% | -19.2% |
| Q4 2020 | $28,055,000 | +85.4% | 490,471 | -2.2% | 2.48% | +7.7% |
| Q3 2020 | $15,133,000 | -7.6% | 501,584 | 0.0% | 2.30% | -83.1% |
| Q2 2020 | $16,382,000 | +21.9% | 501,584 | 0.0% | 13.62% | +19.0% |
| Q1 2020 | $13,437,000 | -56.1% | 501,584 | -49.8% | 11.45% | -12.8% |
| Q4 2019 | $30,620,000 | +27.1% | 1,000,000 | 0.0% | 13.13% | +14.9% |
| Q3 2019 | $24,090,000 | -4.9% | 1,000,000 | 0.0% | 11.43% | +1.6% |
| Q2 2019 | $25,340,000 | -14.8% | 1,000,000 | -34.5% | 11.24% | -53.3% |
| Q1 2019 | $29,759,000 | +26.0% | 1,526,122 | -14.7% | 24.10% | -61.1% |
| Q4 2018 | $23,611,000 | – | 1,790,102 | – | 62.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |